Is controversy about ‘transfer factor therapy’ nearing an end?
- 30 June 1983
- journal article
- Published by Elsevier in Immunology Today
- Vol. 4 (6) , 157-161
- https://doi.org/10.1016/0167-5699(83)90002-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Treatment of Mycobacterium fortuitum pulmonary infection with “transfer factor” (TF): New methodology for evaluating TF potency and predicting clinical responseClinical Immunology and Immunopathology, 1982
- The state of transfer factorImmunology Today, 1982
- Transfer Factor for the Prevention of Varicella-Zoster Infection in Childhood LeukemiaNew England Journal of Medicine, 1980
- In vitro transfer of specific reactivity to cytomegalovirus and candida to cord blood leukocytes with dialyzable leukocyte extractsClinical Immunology and Immunopathology, 1979
- A double-blind evaluation of transfer factor therapy of HBsAg-positive chronic aggressive hepatitis: Preliminary report of efficacyCellular Immunology, 1979
- Transfer factor treatment of chronic mucocutaneous candidiasis: Requirement for donor reactivity to Candida antigenClinical Immunology and Immunopathology, 1978
- In vitro and in vivo studies of the target cell for dialyzable leukocyte extractsClinical Immunology and Immunopathology, 1977
- Specificity of transfer factorNature, 1976
- Tumor-specific cell-mediated immunity in household contacts of cancer patients..Journal of Clinical Investigation, 1975
- THE TRANSFER IN HUMANS OF DELAYED SKIN SENSITIVITY TO STREPTOCOCCAL M SUBSTANCE AND TO TUBERCULIN WITH DISRUPTED LEUCOCYTES 12Journal of Clinical Investigation, 1955